Search

Search Results

• Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: a case report and literature review

  Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac

  23-10-2024

  https://doi.org/10.4081/dr.2024.10010

  685

  PDF: 396

  SUPPLEMENTARY MATERIAL: 181

  HTML: 46
• 

  HLA-DRB1 and DQB1 genetic susceptibility to pemphigus vulgaris and pemphigus foliaceus in Vietnamese patients

  The Bich Thanh Vuong, Duc Minh Do, Phuc Thinh Ong, Thai Van Thanh Le

  05-08-2021

  https://doi.org/10.4081/dr.2021.9286

  5190

  PDF: 748

  HTML: 34

• Genetic variations in the ST18 gene and their association with pemphigus vulgaris in Vietnamese patients: insights from a case series

  Thi Xuan Tam Huynh, Long Phan Son

  22-04-2025

  https://doi.org/10.4081/dr.2025.10265

  492

  PDF: 278

  HTML: 16

• Serum interleukin-6 concentration in patients with pemphigus

  Thai Van Thanh Le, Anh Tuan Ngo, Quoc Hung Ta, The Bich Thanh Vuong

  01-02-2024

  https://doi.org/10.4081/dr.2024.9868

  913

  PDF: 473

  HTML: 26
• 

  Association of single-nucleotide NR3C1 gene polymorphisms with glucocorticosteroid responsiveness in patients with pemphigus vulgaris

  Thai Van Thanh Le, Duy Quan Nguyen, Ngoc Dang Tran, Hoang Kim Tu Trinh

  05-10-2021

  https://doi.org/10.4081/dr.2021.9190

  4197

  PDF: 573

  HTML: 14
• 

  Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

  Roberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, Marzia Caproni, Luca Fania, Giovanni Di Zenzo, Biagio Didona, Giulia Gasparini, Emanuele Cozzani, Claudio Feliciani

  14-06-2023

  https://doi.org/10.4081/dr.2023.9641

  1077

  PDF: 510

  HTML: 32
• 

  Pemphigus vulgaris mimicking Steven-Johnson syndrome/toxic epidermal necrolysis: report of an unusual case

  Latifah Albrahim, Amal Aboud Alasmari, Majed Aleissa

  23-05-2023

  https://doi.org/10.4081/dr.2023.9649

  1866

  PDF: 534

  HTML: 44

• The efficacy of apremilast in pemphigus: a systematic review of case reports

  Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri

  07-05-2025

  https://doi.org/10.4081/dr.2025.10245

  1028

  PDF: 455

  SUPPLEMENTARY MATERIAL: 64

  HTML: 18
• 

  Cicatricial alopecia associated with pemphigus

  Roberto D'Astolto, Chiara Zangrando, Claudio Feliciani

  14-06-2023

  https://doi.org/10.4081/dr.2023.9653

  664

  PDF: 445

  HTML: 27

• 68 | FULMINANT SJS/TEN-LIKE PEMPHIGUS VULGARIS WITH HIGH ANTI-DSG1 TITERS AND CMV REACTIVATION: AN IMMUNOLOGICAL CHALLENGE R. Daher², A. Verdelli¹, L. Sanna², V. Corti², A. Magnatta², S. Landini², M. Donati³, I. Bonanni¹, A. Corrà⁴, V. Ruffo Di Calabria⁵, E. Mariotti⁶, C. Della Bella⁷, L. Giovannoni⁸, M. D'Elios⁷, A. Moggi Pignone⁹, M. Caproni¹ | (1)Rare Dermatological Diseases Unit, Department of Health Sciences, University of Florence, Florence, Italy; (2)Section of Dermatology, Department of Health Sciences, University of Florence, Florence, Italy; (3)Dermatology Department, University of Modena and Reggio Emilia, Modena, Italy; (4)Dermatology Unit, Ospedale San Bortolo, Vicenza, Italy; (5)SSD Dermatologia, Cardinal Massaia Hospital, Asti, Italy; (6)Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; (7)Department of Molecular and Developmental Medicine, University of Siena, Italy; (8)UOC Ricerca e Sviluppo Clinical Practice, AOU Careggi, Florence, Italy; (9)Department of Experimental and Clinical Medicine, Division of Internal Medicine, University of Florence, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11115

  0

  PDF: 0

• The efficacy and safety of intravenous immunoglobulin in pemphigus vulgaris and bullous pemphigoid: a systematic review and meta-analysis

  Hatem Alwusaidi, Mohammed Alahmadi, Sara Alghamdi, Sarah Almulla, Zaker Khoj, Yousef Al Mashhrawi, Shahd Aleid, Jana Alwusaidi

  07-09-2026

  https://doi.org/10.4081/dr.2026.10560

  175

  PDF: 109

  SUPPLEMENTARY MATERIAL: 14
• 

  Rituximab for linear immunoglobulin A bullous dermatosis

  Rummit Dhillon, Lily Park, Sarah Gabros, Tam Nguyen, Stanley Skopit

  29-12-2022

  https://doi.org/10.4081/dr.2023.9574

  1612

  PDF: 587

  HTML: 43

• Venous thromboembolism in bullous pemphigoid: current evidence from an updated systematic review

  Atheer G. Almutairi, Abeer G. Almutairi, Rahaf R. Almutairi, Asem Shadid, Alhanouf A. Bin Dakhil, Lamia Alakrash

  29-01-2025

  https://doi.org/10.4081/dr.2025.10257

  889

  PDF: 413

  SUPPLEMENTARY MATERIAL: 87

  HTML: 10
• 

  A new combination of multiple autoimmune syndrome? Coexistence of vitiligo, autoimmune thyroid disease and ulcerative colitis

  Firdevs Topal, Engin Senel, Sabiye Akbulut, Fatih Topal, Yasemin Dolek

  e19

  15-09-2011

  https://doi.org/10.4081/dr.2011.e19

  3408

  PDF: 1026

  HTML: 360
• 

  Ethnicity is a major determinant of the pattern of dermatological diseases among pilgrims during the Hajj in 2019

  Futoun Sharaf, Marwa El-Samongy, Nahla Bouqellah, Abdullah Al-Madani, Mohammad Abu-Alruhaylah, Yasir Ashour, Najla Dar-Odeh, Osama Abu-Hammad

  17-03-2021

  https://doi.org/10.4081/dr.2021.8934

  4078

  PDF: 718

  HTML: 15

• Linear immunoglobulin A bullous dermatosis induced by atezolizumab

  Seba Almutairi, Dana Alessa

  08-02-2024

  https://doi.org/10.4081/dr.2024.9923

  622

  PDF: 587

  HTML: 42

• The tongue: a bridge between physiology and disorder

  Sabrine Nsir, Ghada Bouslama, Fadwa Ghanmi, Hanen Boukhris, Lamia Oualha, Souha Ben Youssef

  07-02-2025

  https://doi.org/10.4081/dr.2025.10262

  689

  PDF: 750

  SUPPLEMENTARY: 116

  HTML: 35
• 

  Bullous pemphigoid and radiotherapy: case report and literature review update

  Antonio Piras, Bruno Fionda, Antonella Sanfratello, Andrea D'Aviero, Giovanni Sortino, Gianfranco Pernice, Luca Boldrini, Tommaso Angileri, Antonino Daidone

  01-01-2022

  https://doi.org/10.4081/dr.2022.9170

  2151

  PDF: 737

  HTML: 32

• The impact of COVID-19 pandemic on dermatology patients with rare skin diseases

  Migena Vargu, Sabina Dedej, Ermira Vasili

  02-02-2024

  https://doi.org/10.4081/dr.2024.9879

  836

  PDF: 715

  HTML: 33

• Stevens-Johnson induced by imiquimod 5% cream: a case report

  Ilaria Trave, Ilaria Salvi, Claudia Micalizzi, Riccardo Castelli, Aurora Parodi, Emanuele Cozzani

  19-04-2024

  https://doi.org/10.4081/dr.2024.9930

  779

  PDF: 547

  HTML: 26

• Risk factors for fragility fractures in patients with immunobullous diseases on long-term systemic glucocorticoids

  Liau MeiQi May, Nisha Suyien Chandran

  04-03-2024

  https://doi.org/10.4081/dr.2024.9813

  647

  PDF: 416

  HTML: 25

• Gemcitabine, a rare cause of chemotherapy-related reticulate hyperpigmentation

  Francesco Savoia, Matelda Medri, Alessandro Passardi, Davide Melandri, Ignazio Stanganelli

  02-02-2024

  https://doi.org/10.4081/dr.2024.9872

  764

  PDF: 512

  HTML: 45
• 

  A case of post-inflammatory warty dyskeratoma of the chest: Other dermoscopic features

  Vito Ingordo, Gerardo Ferrara, Irene Ingordo, Giuseppe Argenziano

  22-10-2020

  https://doi.org/10.4081/dr.2020.8791

  1345

  PDF: 509

  Appendix: 186

  HTML: 71
• 

  Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients, and vaccine-associated dermatoses: a clinical atlas and a large original study of two general COVID-19 centers from Iran

  Afsaneh Sadeghzadeh-Bazargan, Azadeh Goodarzi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9473

  1029

  PDF: 496

  SUPPLEMENTARY FILE: 165

  HTML: 25